PHARMAC - Latest News [Page 1]

PHARMAC Acknowledges The Work Of Pharmacists

Thursday, 24 September 2020, 10:08 am | PHARMAC

As millions of pharmacists celebrate the 10th anniversary of World Pharmacists Day tomorrow, PHARMAC’s Chief Executive Sarah Fitt acknowledges the extraordinary work done by New Zealand pharmacists and pharmacy staff this year. “It feels appropriate ... More >>

PHARMAC Seeking Views On Widened Access To Juvenile Idiopathic Arthritis Medicines

Friday, 11 September 2020, 9:08 am | PHARMAC

PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to enable more young people with juvenile idiopathic arthritis to benefit from these medicines. Juvenile idiopathic arthritis (JIA) is ... More >>

PHARMAC Seeking Views On New Type 2 Diabetes Medicines

Wednesday, 9 September 2020, 12:07 pm | PHARMAC

PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2 diabetes. The medicines are empagliflozin (brand name Jardiance), empagliflozin with metformin (brand name Jardiamet), and ... More >>

Oral Contraceptive In Short Supply

Thursday, 6 August 2020, 1:17 pm | PHARMAC

PHARMAC has today advised healthcare professionals that a combined oral contraceptive, Brevinor-1 28 Day, is in short supply due to manufacturing delays. Brevinor-1 28 Day (ethinyloestradiol 35 mcg with norethisterone 1 mg) is a funded combined oral ... More >>

PHARMAC Considering A New Way Of Contracting For Medicines

Tuesday, 4 August 2020, 12:22 pm | PHARMAC

Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone wanting to have their say about our annual tender process and a proposal to modify our contracting arrangements. Every year PHARMAC invites tenders ... More >>

Paracetamol 500mg Tablets In Short Supply At Pharmacies

Friday, 17 July 2020, 5:05 pm | PHARMAC

PHARMAC has today updated healthcare professionals that paracetamol 500mg tablets for dispensing in pharmacies are in short supply due to global supply issues caused by COVID-19, and work is underway to secure more stock. “COVID-19 is impacting ... More >>

PHARMAC To Remove Medicine Dispensing Restrictions

Thursday, 9 July 2020, 9:39 am | PHARMAC

Most funded medicines will return to all at once dispensing because PHARMAC is removing most of the temporary dispensing restrictions put in place to manage supply during COVID-19. The change will be effective from midnight Friday 31 July 2020. “This ... More >>

Independent Review Of Lamotrigine Sole Supply Decision By PHARMAC

Friday, 5 June 2020, 10:11 am | PHARMAC

An independent review on the lamotrigine sole-supply decision has found that PHARMAC’s processes were evidence based and robust, and of a high standard. The review was published on the PHARMAC website today and shared with people who had been engaging ... More >>

PHARMAC To Fund New Cystic Fibrosis Medicine

Saturday, 30 May 2020, 8:35 am | PHARMAC

From Monday a new medicine is being funded by PHARMAC which will help young children with cystic fibrosis digest their food more easily. Creon Micro, supplied by Mylan, is a modified-release granule formulation of pancreatic enzymes. It enables smaller ... More >>

PHARMAC Places Temporary Dispensing Limits On All Funded Community Medicines

Thursday, 26 March 2020, 1:30 pm | PHARMAC

PHARMAC is placing temporary dispensing limits on all funded community medicines from Friday 27 March 2020. Changes will be made to the Pharmaceutical Schedule, which is a list of the prescription medicines and therapeutic products subsidised by the ... More >>

PHARMAC Funds New Medicine (mepolizumab) For Severe Asthma

Thursday, 12 March 2020, 12:42 pm | PHARMAC

Around 500 New Zealanders who have severe asthma will have access to a new medicine, mepolizumab, from next month. Severe asthma sufferers who use mepolizumab are less likely to end up in hospital and less likely to experience their symptoms getting ... More >>

PHARMAC seeking views on new cystic fibrosis medicine

Friday, 24 January 2020, 1:01 pm | PHARMAC

PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) for people with cystic fibrosis. More >>

PHARMAC considering new medicines for type 2 diabetes

Wednesday, 15 January 2020, 4:44 pm | PHARMAC

PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living with type 2 diabetes. More >>

PHARMAC seeking views on new breast cancer medicine

Wednesday, 15 January 2020, 10:01 am | PHARMAC

PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) for first-line and second-line treatment of certain types of breast cancer. More >>

Spinraza funding application reviewed

Tuesday, 17 December 2019, 9:28 am | PHARMAC

PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for spinal muscular atrophy, is funded in New Zealand. More >>

PHARMAC to fund more cancer medicines and faster assessment

Thursday, 5 December 2019, 9:09 am | PHARMAC

Thousands of New Zealanders with lymphoma, breast, ovarian and blood cancers will have more treatment options available to them in the New Year. More >>

PHARMAC widening access to the meningococcal ACWY vaccine

Thursday, 14 November 2019, 9:38 am | PHARMAC

The meningococcal ACWY vaccine will be available free from next month for young people in close living situations. More >>

PHARMAC funding new leukaemia medicine

Monday, 4 November 2019, 10:19 am | PHARMAC

New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live longer from 1 December 2019. More >>

21,000 to benefit from Mirena and Jaydess

Monday, 14 October 2019, 9:27 am | PHARMAC

PHARMAC is widening funded access to Mirena, as well as listing a new long-acting reversible contraceptive option, Jaydess, which will benefit around 21,000 New Zealand women. More >>

PHARMAC signs bundle deal for more cancer medicines

Monday, 7 October 2019, 1:41 pm | PHARMAC

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More >>

 

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL